Articles

Steven H. Collis, who currently holds the position, will transition to executive chair of the board.

A Changing of the Guard: Robert P. Mauch to Become CEO in October 2024

The Asia-Pacific location is expected to provide serialization solutions for counterfeit medication entering the pharma supply chain. 

Advanco Opens New Office in Singapore

The latest news for pharma industry insiders.

Pharma Pulse 3/13/24: Navigating the Mental Health Challenges of Cancer, Putting Menopause Medication on the Main Stage & more

A sit-down with Groovy Singh, CEO of Bright Green Corporation, who describes the waves in the global supply chain the company is making after being authorized to grow cannabis, along with cannabis-related products.

Adopting New Manufacturing Technologies 

A qualitative study explores how these drugs are impacting these patients’ lives, while digging deeper into the possibility of deprescribing, with insight from primary care physicians. 

Older Adults’ Experience with Opioid Use, Deprescribing

The company’s twice-daily, branded ruxolitinib cream 1.5% presents a significant reduction in abscess and inflammatory nodule (AN) count for the treatment of Hurley stage 1 or 2 (mild-to-moderate) hidradenitis suppurativa.

Incyte’s Phase II Study for Opzelura Returns Promising Results in Adult Patients

A USC study discovers that an increasing share of both generic and brand-name meds are being excluded from approval. 

Taking a Closer Look at Medicare Part D’s Rising Drug Coverage Restrictions

Pharma Pulse 3/11/24: Yogurt May Reduce Diabetes Risk, Tech Evangelist's Dreams for AI Tutors Might be Too Big & more

With out-of-pocket healthcare costs resulting in financial issues for patients, a cross-sectional study closely examines whether they are linked to more premature deaths.  

Is There a Correlation Between Medical Debt and Health Status?

A proposed Senate bill is intended to protect citizens’ private health and genetic information.

News